1. MicroRNA profiles as predictive markers of response to azacitidine therapy in myelodysplastic syndromes and acute myeloid leukemia
   Zdenek Krejcik et al, 2018, Cancer Biomarkers CrossRef
2. The Effects of Resveratrol, Gallic Acid, and Piperine on the Expression of miR-17, miR-92b, miR-181a, miR-222, BAX, BCL-2, MCL-1, WT1, c-Kit, and CEBPA in Human Acute Myeloid Leukemia Cells and Their Roles in Apoptosis
   Mahdiyar Iravani Saadi et al, 2023, Biochemical Genetics CrossRef
3. Predictors of clinical responses to hypomethylating agents in acute myeloid leukemia or myelodysplastic syndromes
   Hong Wang et al, 2018, Annals of Hematology CrossRef
4. MicroRNAs and response to therapy in leukemia
   Hossein Sharifi et al, 2019, Journal of Cellular Biochemistry CrossRef
5. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer
   Shaohua Ge et al, 2019, Investigational New Drugs CrossRef
6. MicroRNAs as New Biomarkers for Diagnosis and Prognosis, and as Potential Therapeutic Targets in Acute Myeloid Leukemia
   Stefania Trino et al, 2018, International Journal of Molecular Sciences CrossRef
7. The Pervasive Role of the miR-181 Family in Development, Neurodegeneration, and Cancer
   Alessia Indrieri et al, 2020, International Journal of Molecular Sciences CrossRef
8. Aberrant Expression of the miR-181b/miR-222 after Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
   Mahdiyar Iravani Saadi et al, 2019, Indian Journal of Hematology and Blood Transfusion CrossRef
9. Noncoding RNAs in Myelodysplastic Syndromes
   Andrea Hruštincová et al, 2019, Recent Developments in Myelodysplastic Syndromes CrossRef
10. Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia
    Ying Shen et al, 2022, Acta Haematologica CrossRef
11. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
    Peter McAnena et al, 2019, BMC Cancer CrossRef
12. microRNA expression in acute myeloid leukaemia: New targets for therapy?
    Daniel Fletcher et al, 2022, eJHaem CrossRef
13. The emergence of drug resistance to targeted cancer therapies: Clinical evidence
    Ana Bela Sarmento-Ribeiro et al, 2019, Drug Resistance Updates CrossRef
14. Resistance to Hypomethylating Agents in Myelodysplastic Syndrome and Acute Myeloid Leukemia From Clinical Data and Molecular Mechanism
    Guangjie Zhao et al, 2021, Frontiers in Oncology CrossRef
15. Role of Serum miR-181b, Proinflammatory Cytokine, and Adhesion Molecules in Behçet's Disease
    Noha Ahmed El Boghdady et al, 2019, Journal of Interferon & Cytokine Research CrossRef
16. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins
    Marcus Bauer et al, 2020, International Journal of Molecular Sciences CrossRef
17. MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis
    Qiang Guo et al, 2017, Oncotarget CrossRef
18. Double-edged sword role of miRNA-633 and miRNA-181 in human cancers
    Jitendra Gupta et al, 2023, Pathology - Research and Practice CrossRef
19. High Diagnostic and Prognostic Value of miRNAs Compared with the Carcinoembryonic Antigen As A Traditional Tumor Marker
    Neda Yaghoubi et al, 2022, Anti-Cancer Agents in Medicinal Chemistry CrossRef